Antiretroviral Therapy with a Twice-Daily Regimen Containing 400 Milligrams of Indinavir and 100 Milligrams of Ritonavir in Human Immunodeficiency Virus Type 1-Infected Women during Pregnancy

We evaluated the safety and efficacy of a twice daily regimen containing 400 mg of indinavir and 100 mg of ritonavir in 32 human immunodeficiency virus (HIV)-infected women during pregnancy. The median indinavir trough concentration was 208 ng/ml during the third trimester. At delivery, 26 of 28 wom...

Full description

Saved in:
Bibliographic Details
Main Authors: Ghosn, Jade, De Montgolfier, Ines, Cornélie, Chantal, Dominguez, Stéphanie, Pérot, Claire, Peytavin, Gilles, Marcelin, Anne-Geneviève, Pauchard, Michèle, Ouagari, Zineb, Bonmarchand, Manuela, Agher, Rachid, Calvez, Vincent, Bricaire, François, Dommergues, Marc, Katlama, Christine, Tubiana, Roland
Format: Artigo
Language:Inglês
Published: American Society for Microbiology (ASM) 2008
Subjects:
Antiviral Agents
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2292558/
https://ncbi.nlm.nih.gov/pubmed/18250187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01301-07
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items